Ads
related to: acute lymphocytic leukemia- ALL Treatment Option
Component of Multi-Agent
Chemotherapy for ALL
- About Treatment
Learn About a Potential
ALL Treatment Option.
- Ordering Guide
View HCP Resources and
Download Ordering Guide
- Dosing Schedule
Physicians, View Dosing Schedule
and Administration Info.
- Clinical Data
View Safety &
Clinical Data Profile.
- Patient Support
Learn More About
Patient Assistance Options.
- ALL Treatment Option
Search results
Young girl survives cancer thanks to little sister’s lifesaving donation: 'A perfect match'
Fox News via Yahoo News· 5 days agoA 10-year-old girl in the U.K. who had acute lymphoblastic leukemia is in remission thanks to her...
9-year-old girl surprised with first pitch at Buffalo Bisons game
WKBW-TV Buffalo· 1 day agoThis night was a special one for Mya, who is a big baseball fan herself. In 2021, she was diagnosed with B-cell Acute Lymphoblastic Leukemia. Thankfully, Mya is now in remission
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis
FOX 8 Cleveland· 4 days agoCalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused...
CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers
MedPage Today· 4 days agoA strategy of sequential CD7 chimeric antigen receptor (CAR) T-cell therapy and haploidentical...
Analysts Set Beam Therapeutics Inc. (NASDAQ:BEAM) Price Target at $41.00
ETF DAILY NEWS· 6 days agoShares of Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) have received a consensus rating of “Hold” from the thirteen analysts that are currently covering the stock, MarketBeat reports ...
Girl in cancer remission thanks to sister’s lifesaving donation
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoA schoolgirl who was diagnosed with a rare blood cancer went into remission - thanks to her little...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Vontobel Holding Ltd.
ETF DAILY NEWS· 5 days agoVontobel Holding Ltd. lessened its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 6.0% during the fourth quarter, according to the company in its most recent 13F filing with ...
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Zacks via Yahoo Finance· 2 days agoTecartus sales increased 13% year over year to $100 million, driven by increased demand in adult R/R...
Jazz Pharmaceuticals (JAZZ) Set to Announce Earnings on Wednesday
ETF DAILY NEWS· 4 days agoJazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce ...
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Zacks via Yahoo Finance· 6 days agoTecartus (brexucabtagene autoleucel) sales are being driven by increased demand in adult R/R B-cell...
Ads
related to: acute lymphocytic leukemia